Effects of cognitive remediation therapy versus other interventions on cognitive functioning in schizophrenia inpatients.


Journal

Neuropsychological rehabilitation
ISSN: 1464-0694
Titre abrégé: Neuropsychol Rehabil
Pays: England
ID NLM: 9112672

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 2 5 2017
medline: 18 1 2019
entrez: 2 5 2017
Statut: ppublish

Résumé

Computerised cognitive remediation therapy (CCRT) has been shown to improve cognitive function in individuals with schizophrenia beyond effects of other forms of therapy. However, results vary between studies, and most are aimed at individuals who are living in the community. Very few studies have investigated its efficacy in psychiatric wards in order to assess whether or not this is a suitable site to start the therapy. This study evaluated CCRT efficacy among schizophrenia inpatients who received a broad range of therapeutic interventions in a psychiatric ward. A randomised controlled trial of CCRT versus an active control in 66 young inpatients with a diagnosis of schizophrenia was conducted. The intervention lasted for 6 weeks and its efficacy was assessed with the composite score of the MATRICS Consensus Cognitive Battery. Both groups improved similarly in cognitive function and psychopathological symptoms. However, the CCRT group improved more than the controls in negative symptoms. This result shows that providing a drill and practice cognitive remediation to inpatients does not produce benefits for cognitive functioning substantially greater than other forms of therapy provided in a ward, but it is more efficient in reduction of negative symptoms. Our results suggest that CRT might be considered as a promising intervention for reducing negative symptoms in schizophrenia individuals.

Identifiants

pubmed: 28457189
doi: 10.1080/09602011.2017.1317641
doi:

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

477-488

Subventions

Organisme : Department of Health
ID : RP-PG-0612-20002
Pays : United Kingdom

Auteurs

Magdalena Linke (M)

a Third Department of Psychiatry , Institute of Psychiatry and Neurology , Warsaw , Poland.

Konrad S Jankowski (KS)

b Faculty of Psychology , University of Warsaw , Warsaw , Poland.

Adam Wichniak (A)

a Third Department of Psychiatry , Institute of Psychiatry and Neurology , Warsaw , Poland.

Marek Jarema (M)

a Third Department of Psychiatry , Institute of Psychiatry and Neurology , Warsaw , Poland.

Til Wykes (T)

c Department of Psychology , Institute of Psychiatry, King's College London , London , United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH